RESPIVAX Trademark
RESPIVAX is a USPTO trademark filed by HUVEPHARMA INC.. Status: Registered.
Trademark Facts
| Mark | RESPIVAX |
|---|---|
| Serial Number | 87721290 |
| Registration Number | 6048109 |
| Status | Registered |
| Filing Date | 2017-12-14 |
| Registration Date | 2020-05-05 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | HUVEPHARMA INC. |
| Attorney of Record | Charles G. Zug |
| Prosecution Events | 37 |
| Latest Event | REM1 on 2025-05-05 |
Goods & Services
Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; bacteriophage antimicrobials for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; immunorestorative biopharmaceuticals for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; parasiticides; insecticides; medicinal drugs for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; dietary supplements; and hormone preparations